Myelodysplastic Syndrome Stem Cells Evaluated By Multiparameter Flow Cytometry Are Associated with Posttreatment Relapse: A Prospective Study

• Published in: Blood Vol. 144; no. Supplement 1; p. 1834
• Main Authors: Wu, Wei-Bin, Luo, Ya-Wen, Li, Siqi, Xu, Lanping, Wang, Yu, Zhang, Xiaohui, Sun, Yuqian, Tang, Feifei, Mo, Xiaodong, Liu, Kai-Yan, Zhao, Xiao-Su, Zhao, Xiang-Yu, Chen, He-Bing, Chang, Ying-Jun, Huang, Xiaojun
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 05.11.2024
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2024-207920

Background: We previously showed that leukemia stem cell (LSC)-based measurable residual disease (MRD) assay (Leukemia,2016;30:439-446), mainly including a cocktail panel of CD7, CD11b, CD22, CD56, CD366, and CD371 on CD34+CD38- cells, is superior to traditional multiparameter flow cytometry (MFC) m...